Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201

Analysis of synthetic cannabinoids in “spice-like” herbal highs: snapshot of the German market in summer 2011

(2012) Karoline Simolka et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromatography system

(2012) Bjoern Moosmann et al.   FORENSIC SCIENCE INTERNATIONAL

Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated “herbal” products circulated in the Tokyo area

(2012) Jun’ichi Nakajima et al.   Forensic Toxicology

Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products

(2012) Nahoko Uchiyama et al.   Forensic Toxicology

Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures

(2012) Stefan Kneisel et al.   Forensic Toxicology

Purity of Synthetic Cannabinoids Sold Online for Recreational Use

(2012) Brett C. Ginsburg et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Synthetic Cannabinoid Use

(2012) DANIEL CASTELLANOS et al.   Journal of Psychiatric Practice

Clinical Presentation of Intoxication Due to Synthetic Cannabinoids

(2012) Joanna Cohen et al.   PEDIATRICS

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

(2012) Kathryn A. Seely et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Comparison of “herbal highs” composition

(2011) Dariusz Zuba et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Identification of a Novel Cannabimimetic Phenylacetylindole, Cannabipiperidiethanone, as a Designer Drug in a Herbal Product and Its Affinity for Cannabinoid CB1 and CB2 Receptors

(2011) Nahoko Uchiyama et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Severe Toxicity Following Synthetic Cannabinoid Ingestion

(2011) J. Lapoint et al.   CLINICAL TOXICOLOGY

Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)

(2011) Adrian Derungs et al.   CLINICAL TOXICOLOGY

A survey study to characterize use of Spice products (synthetic cannabinoids)

(2011) Ryan Vandrey et al.   DRUG AND ALCOHOL DEPENDENCE

The emergence and analysis of synthetic cannabinoids

(2011) Simon Hudson et al.   Drug Testing and Analysis

Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet

(2011) Jun’ichi Nakajima et al.   Forensic Toxicology

Identification and quantitation of a benzoylindole (2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone and a naphthoylindole 1-(5-fluoropentyl-1H-indol-3-yl)-(naphthalene-1-yl)methanone (AM-2201) found in illegal products obtained via the Internet and their cannabimimetic effects evaluated by in vitro [35S]GTPγS binding assays

(2011) Jun’ichi Nakajima et al.   Forensic Toxicology

Survey of current trends in the abuse of psychotropic substances and plants in Japan

(2011) Ruri Kikura-Hanajiri et al.   Legal Medicine

Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2

(2011) A. Mir et al.   PEDIATRICS

Beyond THC: The New Generation of Cannabinoid Designer Drugs

(2011) Liana Fattore et al.   Frontiers in Behavioral Neuroscience

Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products

(2010) Nahoko Uchiyama et al.   Forensic Toxicology

Identification and quantitation of cannabimimetic compound JWH-250 as an adulterant in products obtained via the Internet

(2010) Jun’ichi Nakajima et al.   Forensic Toxicology

Increased Blood Pressure After Abrupt Cessation of Daily Cannabis Use

(2010) Ryan Vandrey et al.   Journal of Addiction Medicine

“Spice” Girls: Synthetic Cannabinoid Intoxication

(2010) Aaron B. Schneir et al.   JOURNAL OF EMERGENCY MEDICINE

Panic Attack after Spice Abuse in a Patient with ADHD

(2010) H. Müller et al.   PHARMACOPSYCHIATRY

The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes

(2010) Helge Müller et al.   SCHIZOPHRENIA RESEARCH

Spice drugs as a new trend: Mode of action, identification and legislation

(2010) I. Vardakou et al.   TOXICOLOGY LETTERS

Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product

(2009) Nahoko Uchiyama et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Identification of a cannabimimetic indole as a designer drug in a herbal product

(2009) Nahoko Uchiyama et al.   Forensic Toxicology

‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?

(2009) Volker Auwärter et al.   JOURNAL OF MASS SPECTROMETRY